ZBH · Zimmer Biomet Holdings, Inc.
$93.102026-07-21Sector: Healthcare; Industry: Medical - Devices; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$42
-54.7% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($42 · $34) Analysts Range ($83 · $120) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $7.4B | — | 18.6% | 3.1% | $1.3B | −$114MM | $1.2B | 6.4% | — | 6.9% | $19.3B | $5.23 | — |
| 2024.Q4 | $7.4B | 0.0% | 18.6% | 12.7% | $1.2B | −$192MM | $1.0B | 7.2% | — | 6.2% | $19.5B | $5.23 | — |
| 2025.Q1 | $7.7B | 3.8% | 18.0% | 12.9% | $1.2B | $18MM | $1.2B | 6.6% | — | 6.2% | $19.5B | $4.62 | — |
| 2025.Q4 | $7.7B | 0.0% | 18.0% | 15.1% | $1.2B | −$198MM | $976MM | 7.0% | — | 5.8% | $20.9B | $4.62 | — |
| 2026.Q1 | $8.4B | 9.5% | 16.8% | 15.8% | $1.2B | −$274MM | $916MM | 6.5% | — | 5.7% | $21.1B | $3.89 | 12.9 |
| italics below = DCF projection · 10yr Rev CAGR: 3.9% |
| 2027.Q1 | $8.6B | +2.6% | 17.9% | 16.2% | $1.3B | −$554MM | $737MM | 7.7% | $684MM | 6.0% | $21.6B | $6.13 | 15.2 |
| 2028.Q1 | $8.9B | +3.6% | 18.3% | 16.6% | $1.4B | −$805MM | $555MM | 7.8% | $478MM | 6.2% | $22.4B | $6.45 | 14.4 |
| 2029.Q1 | $9.3B | +4.0% | 18.9% | 17.0% | $1.5B | −$956MM | $500MM | 7.9% | $399MM | 6.4% | $23.4B | $6.91 | 13.5 |
| 2030.Q1 | $9.7B | +4.2% | 19.7% | 17.4% | $1.6B | −$1.1B | $511MM | 8.0% | $378MM | 6.6% | $24.4B | $7.47 | 12.5 |
| 2031.Q1 | $10.1B | +4.2% | 19.7% | 17.9% | $1.6B | −$1.1B | $502MM | 8.1% | $344MM | 6.5% | $25.6B | $7.74 | 12.0 |
|
| Term. Yr+ | $12.9B | 4.1% | 19.1% | 20.0% | $2.0B | −$937MM | $1.0B | 8.6% | $10.5B | 8.6% | — | — | — |
Active scenario IV: $42 (-54.7% vs market)